[Pulmonary manifestations associated with malaria].
Identifieur interne : 000493 ( PubMed/Corpus ); précédent : 000492; suivant : 000494[Pulmonary manifestations associated with malaria].
Auteurs : P. Hovette ; P. Camara ; P R Burgel ; P S Mbaye ; M. Sane ; F. KlotzSource :
- Revue de pneumologie clinique [ 0761-8417 ] ; 1998.
English descriptors
- KwdEn :
- Adult, Anti-Bacterial Agents (therapeutic use), Antimalarials (therapeutic use), Bronchitis (etiology), Child, Chloroquine (therapeutic use), Female, Humans, Infant, Newborn, Lung Diseases (etiology), Malaria, Falciparum (complications), Malaria, Falciparum (diagnosis), Malaria, Falciparum (therapy), Male, Mefloquine (therapeutic use), Oxygen Inhalation Therapy, Phenanthrenes (therapeutic use), Pleurisy (etiology), Pregnancy, Pregnancy Complications, Parasitic (diagnosis), Pregnancy Complications, Parasitic (therapy), Pulmonary Edema (etiology), Quinidine (therapeutic use), Quinine (therapeutic use), Respiratory Distress Syndrome, Newborn (etiology), Travel.
- MESH :
- chemical , therapeutic use : Anti-Bacterial Agents, Antimalarials, Chloroquine, Mefloquine, Phenanthrenes, Quinidine, Quinine.
- complications : Malaria, Falciparum.
- diagnosis : Malaria, Falciparum, Pregnancy Complications, Parasitic.
- etiology : Bronchitis, Lung Diseases, Pleurisy, Pulmonary Edema, Respiratory Distress Syndrome, Newborn.
- therapy : Malaria, Falciparum, Pregnancy Complications, Parasitic.
- Adult, Child, Female, Humans, Infant, Newborn, Male, Oxygen Inhalation Therapy, Pregnancy, Travel.
Abstract
Pulmonary manifestations are frequently observed in children, pregnant women and travellers with malaria. The pathophysiology of these pulmonary manifestations is poorly understood but would appear to be secondary to an interaction between the parasitized red cells and the pulmonary capillary endothelium. Bronchitis and pneumonia do not directly compromise outcome but, left unrecognized, the delay in diagnosis and treatment may be fatal. Acute respiratory distress in children is the first cause of overmortality, coming before neurological involvement. The acute respiratory distress caused by severe malaria has no specific characteristics. Iatrogenic complications and pulmonary superinfections must be differentiated. The prevention of pulmonary manifestations associated with malaria can easily be accomplished by limiting water intake and carefully monitoring urinary output and weight. Treatment is the same as for acute flare-ups in combination with symptomatic respiratory treatment when required.
PubMed: 10100346
Links to Exploration step
pubmed:10100346Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Pulmonary manifestations associated with malaria].</title><author><name sortKey="Hovette, P" sort="Hovette, P" uniqKey="Hovette P" first="P" last="Hovette">P. Hovette</name><affiliation><nlm:affiliation>Services médicaux, l'Hôpital Principal de Dakar, Sénégal.</nlm:affiliation></affiliation></author><author><name sortKey="Camara, P" sort="Camara, P" uniqKey="Camara P" first="P" last="Camara">P. Camara</name></author><author><name sortKey="Burgel, P R" sort="Burgel, P R" uniqKey="Burgel P" first="P R" last="Burgel">P R Burgel</name></author><author><name sortKey="Mbaye, P S" sort="Mbaye, P S" uniqKey="Mbaye P" first="P S" last="Mbaye">P S Mbaye</name></author><author><name sortKey="Sane, M" sort="Sane, M" uniqKey="Sane M" first="M" last="Sane">M. Sane</name></author><author><name sortKey="Klotz, F" sort="Klotz, F" uniqKey="Klotz F" first="F" last="Klotz">F. Klotz</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1998">1998</date><idno type="RBID">pubmed:10100346</idno><idno type="pmid">10100346</idno><idno type="wicri:Area/PubMed/Corpus">000493</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000493</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Pulmonary manifestations associated with malaria].</title><author><name sortKey="Hovette, P" sort="Hovette, P" uniqKey="Hovette P" first="P" last="Hovette">P. Hovette</name><affiliation><nlm:affiliation>Services médicaux, l'Hôpital Principal de Dakar, Sénégal.</nlm:affiliation></affiliation></author><author><name sortKey="Camara, P" sort="Camara, P" uniqKey="Camara P" first="P" last="Camara">P. Camara</name></author><author><name sortKey="Burgel, P R" sort="Burgel, P R" uniqKey="Burgel P" first="P R" last="Burgel">P R Burgel</name></author><author><name sortKey="Mbaye, P S" sort="Mbaye, P S" uniqKey="Mbaye P" first="P S" last="Mbaye">P S Mbaye</name></author><author><name sortKey="Sane, M" sort="Sane, M" uniqKey="Sane M" first="M" last="Sane">M. Sane</name></author><author><name sortKey="Klotz, F" sort="Klotz, F" uniqKey="Klotz F" first="F" last="Klotz">F. Klotz</name></author></analytic><series><title level="j">Revue de pneumologie clinique</title><idno type="ISSN">0761-8417</idno><imprint><date when="1998" type="published">1998</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Anti-Bacterial Agents (therapeutic use)</term><term>Antimalarials (therapeutic use)</term><term>Bronchitis (etiology)</term><term>Child</term><term>Chloroquine (therapeutic use)</term><term>Female</term><term>Humans</term><term>Infant, Newborn</term><term>Lung Diseases (etiology)</term><term>Malaria, Falciparum (complications)</term><term>Malaria, Falciparum (diagnosis)</term><term>Malaria, Falciparum (therapy)</term><term>Male</term><term>Mefloquine (therapeutic use)</term><term>Oxygen Inhalation Therapy</term><term>Phenanthrenes (therapeutic use)</term><term>Pleurisy (etiology)</term><term>Pregnancy</term><term>Pregnancy Complications, Parasitic (diagnosis)</term><term>Pregnancy Complications, Parasitic (therapy)</term><term>Pulmonary Edema (etiology)</term><term>Quinidine (therapeutic use)</term><term>Quinine (therapeutic use)</term><term>Respiratory Distress Syndrome, Newborn (etiology)</term><term>Travel</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term><term>Antimalarials</term><term>Chloroquine</term><term>Mefloquine</term><term>Phenanthrenes</term><term>Quinidine</term><term>Quinine</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Malaria, Falciparum</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Malaria, Falciparum</term><term>Pregnancy Complications, Parasitic</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Bronchitis</term><term>Lung Diseases</term><term>Pleurisy</term><term>Pulmonary Edema</term><term>Respiratory Distress Syndrome, Newborn</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Malaria, Falciparum</term><term>Pregnancy Complications, Parasitic</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Child</term><term>Female</term><term>Humans</term><term>Infant, Newborn</term><term>Male</term><term>Oxygen Inhalation Therapy</term><term>Pregnancy</term><term>Travel</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Pulmonary manifestations are frequently observed in children, pregnant women and travellers with malaria. The pathophysiology of these pulmonary manifestations is poorly understood but would appear to be secondary to an interaction between the parasitized red cells and the pulmonary capillary endothelium. Bronchitis and pneumonia do not directly compromise outcome but, left unrecognized, the delay in diagnosis and treatment may be fatal. Acute respiratory distress in children is the first cause of overmortality, coming before neurological involvement. The acute respiratory distress caused by severe malaria has no specific characteristics. Iatrogenic complications and pulmonary superinfections must be differentiated. The prevention of pulmonary manifestations associated with malaria can easily be accomplished by limiting water intake and carefully monitoring urinary output and weight. Treatment is the same as for acute flare-ups in combination with symptomatic respiratory treatment when required.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10100346</PMID><DateCompleted><Year>1999</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0761-8417</ISSN><JournalIssue CitedMedium="Print"><Volume>54</Volume><Issue>6</Issue><PubDate><Year>1998</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Revue de pneumologie clinique</Title><ISOAbbreviation>Rev Pneumol Clin</ISOAbbreviation></Journal><ArticleTitle>[Pulmonary manifestations associated with malaria].</ArticleTitle><Pagination><MedlinePgn>340-5</MedlinePgn></Pagination><Abstract><AbstractText>Pulmonary manifestations are frequently observed in children, pregnant women and travellers with malaria. The pathophysiology of these pulmonary manifestations is poorly understood but would appear to be secondary to an interaction between the parasitized red cells and the pulmonary capillary endothelium. Bronchitis and pneumonia do not directly compromise outcome but, left unrecognized, the delay in diagnosis and treatment may be fatal. Acute respiratory distress in children is the first cause of overmortality, coming before neurological involvement. The acute respiratory distress caused by severe malaria has no specific characteristics. Iatrogenic complications and pulmonary superinfections must be differentiated. The prevention of pulmonary manifestations associated with malaria can easily be accomplished by limiting water intake and carefully monitoring urinary output and weight. Treatment is the same as for acute flare-ups in combination with symptomatic respiratory treatment when required.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hovette</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Services médicaux, l'Hôpital Principal de Dakar, Sénégal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camara</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Burgel</LastName><ForeName>P R</ForeName><Initials>PR</Initials></Author><Author ValidYN="Y"><LastName>Mbaye</LastName><ForeName>P S</ForeName><Initials>PS</Initials></Author><Author ValidYN="Y"><LastName>Sane</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Klotz</LastName><ForeName>F</ForeName><Initials>F</Initials></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Les manifestations pulmonaires associées au paludisme.</VernacularTitle></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Rev Pneumol Clin</MedlineTA><NlmUniqueID>8406312</NlmUniqueID><ISSNLinking>0761-8417</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010616">Phenanthrenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>886U3H6UFF</RegistryNumber><NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>A7V27PHC7A</RegistryNumber><NameOfSubstance UI="D011803">Quinine</NameOfSubstance></Chemical><Chemical><RegistryNumber>ITX08688JL</RegistryNumber><NameOfSubstance UI="D011802">Quinidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q2OS4303HZ</RegistryNumber><NameOfSubstance UI="C023768">halofantrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>TML814419R</RegistryNumber><NameOfSubstance UI="D015767">Mefloquine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001991" MajorTopicYN="N">Bronchitis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016778" MajorTopicYN="N">Malaria, Falciparum</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015767" MajorTopicYN="N">Mefloquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010102" MajorTopicYN="N">Oxygen Inhalation Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010616" MajorTopicYN="N">Phenanthrenes</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010998" MajorTopicYN="N">Pleurisy</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015597" MajorTopicYN="N">Pregnancy Complications, Parasitic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011654" MajorTopicYN="N">Pulmonary Edema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011802" MajorTopicYN="N">Quinidine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011803" MajorTopicYN="N">Quinine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012127" MajorTopicYN="N">Respiratory Distress Syndrome, Newborn</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014195" MajorTopicYN="N">Travel</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1999</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1999</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1999</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10100346</ArticleId><ArticleId IdType="pii">MDOI-RP-12-1998-54-6-0761-8417-101019-ART73</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000493 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000493 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:10100346
|texte= [Pulmonary manifestations associated with malaria].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:10100346" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |